首頁 > 市場調查報告書 > 材料

有機化合物

市場調查報告書

商品編碼

1668117

哌嗪市場 - 全球產業規模、佔有率、趨勢、機會和預測，按來源（天然、合成）、最終用途（醫藥、農業化學品、個人護理和化妝品、其他）、按地區和競爭細分，2020-2030 年預測

Piperazine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Natural, Synthetic), By End-use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others), By Region and Competition, 2020-2030F

出版日期: 2025年02月28日 | 出版商:

TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球哌嗪市場價值為 34.5 億美元，預計到 2030 年將達到 44.9 億美元，預測期內複合年成長率為 4.44%。全球哌嗪市場因其在製藥、化學品和工業過程中的廣泛應用而正在穩步成長。哌嗪是一種含有兩個氮原子的六元雜環結構的有機化合物，主要用作合成各種藥物、樹脂和腐蝕抑制劑的中間體。哌嗪衍生物的需求不斷增加，特別是用於治療寄生蟲感染和神經系統疾病的製藥行業的需求，正在推動市場擴張。根據 MDPI 發表的一篇文章，哌嗪是藥物研發中第三常見的氮雜環化合物，是幾種暢銷藥物的關鍵成分，包括伊馬替尼（以 Gleevec 為商品名銷售）和西地那非（以 Viagra 為商品名銷售）。儘管哌嗪在藥物化學中有著廣泛的應用，但其結構多樣性仍然有限，大約80%的含哌嗪藥物的取代基僅在氮位置上。

市場概況
預測期	2026-2030
2024 年市場規模	34.5 億美元
2030 年市場規模	44.9 億美元
2025-2030 年複合年成長率	4.44％
成長最快的領域	合成的
最大的市場	亞太地區

哌嗪市場的主要促進因素之一是其在製藥業中的作用。哌嗪衍生物如檸檬酸鹽和己二酸鹽通常用作驅蟲藥，用於治療寄生蟲引起的感染。此外，哌嗪是合成精神病藥物和抗發炎藥物的關鍵中間體。寄生蟲感染盛行率的上升，加上對有效藥物的需求不斷增加，推動了哌嗪類藥物的消費。推動市場成長的另一個重要因素是其在化學和聚合物工業中的應用。哌嗪用於生產環氧樹脂，而環氧樹脂是塗料、黏合劑和複合材料中必不可少的原料。此外，它還可作為聚氨酯和聚醯胺樹脂的固化劑，增強其機械性能。建築、汽車和航太工業的不斷發展導致對哌嗪基樹脂和聚合物的需求不斷增加。

主要市場促進因素

藥品需求不斷成長

主要市場挑戰

供應鏈中斷和區域依賴性

主要市場趨勢

碳捕獲技術需求不斷成長

Global Piperazine Market was valued at USD 3.45 Billion in 2024 and is expected to reach USD 4.49 Billion by 2030 with a CAGR of 4.44% during the forecast period. The global piperazine market is witnessing steady growth due to its widespread applications in pharmaceuticals, chemicals, and industrial processes. Piperazine, an organic compound with a six-membered heterocyclic structure containing two nitrogen atoms, is primarily used as an intermediate in the synthesis of various drugs, resins, and corrosion inhibitors. The increasing demand for piperazine derivatives, especially in the pharmaceutical industry for the treatment of parasitic infections and neurological disorders, is driving market expansion. According to an article published in MDPI, piperazine is the third most prevalent nitrogen heterocycle in drug discovery and serves as a crucial component in several blockbuster pharmaceuticals, including Imatinib (marketed as Gleevec) and Sildenafil (sold as Viagra). Despite its extensive application in medicinal chemistry, the structural diversity of piperazines remains limited, with approximately 80% of piperazine-containing drugs featuring substituents exclusively at the nitrogen positions.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.45 Billion
Market Size 2030	USD 4.49 Billion
CAGR 2025-2030	4.44%
Fastest Growing Segment	Synthetic
Largest Market	Asia Pacific

One of the key drivers of the piperazine market is its role in the pharmaceutical industry. Piperazine derivatives such as citrate and adipate salts are commonly used as anthelmintic drugs to treat infections caused by parasitic worms. Additionally, piperazine serves as a critical intermediate in the synthesis of psychiatric and anti-inflammatory drugs. The rising prevalence of parasitic infections, coupled with an increasing demand for effective medications, has boosted the consumption of piperazine-based pharmaceuticals. Another significant factor fuelling market growth is its application in the chemical and polymer industries. Piperazine is used in the production of epoxy resins, which are essential in coatings, adhesives, and composite materials. Also, it acts as a curing agent in polyurethane and polyamide resins, enhancing their mechanical properties. The growing construction, automotive, and aerospace industries are contributing to the rising demand for piperazine-based resins and polymers.

Key Market Drivers

Rising Demand in Pharmaceuticals

The global piperazine market is witnessing significant growth, primarily driven by its expanding application in the pharmaceutical industry. Piperazine, a versatile chemical compound, is widely used in the synthesis of various pharmaceutical drugs, particularly as an intermediate in producing anthelmintic medications, psychotropic drugs, and anti-tuberculosis treatments. The increasing prevalence of parasitic infections and neurological disorders, coupled with rising healthcare expenditures worldwide, is boosting the demand for piperazine-based pharmaceuticals. In March 2024, The Lancet Neurology published a major study revealing that in 2021, over 3 billion people globally had been living with a neurological condition. The World Health Organization (WHO) contributed to the analysis of the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021 data. The study confirmed that neurological conditions had become the leading cause of ill health and disability worldwide. Additionally, the total burden of disability, illness, and premature mortality-measured in disability-adjusted life years (DALYs)-had increased by 18% since 1990.

Key Market Challenges

Supply Chain Disruptions and Regional Dependencies

The global piperazine market is highly dependent on a few key manufacturing regions, such as China and India, which supply a substantial portion of the world's demand. Disruptions caused by trade restrictions, COVID-19-related lockdowns, or logistical bottlenecks can lead to supply shortages and price spikes. Additionally, reliance on a concentrated production base increases market vulnerability, making diversification a necessity but a challenging endeavor for companies seeking alternative suppliers.

Key Market Trends

Rising Demand for Carbon Capture Technologies

The increasing focus on reducing greenhouse gas emissions has led to significant advancements in carbon capture and storage (CCS) technologies, where piperazine-based solvents are playing a crucial role. As industries face stricter environmental regulations, CCS has emerged as a key strategy to curb CO2 emissions from power plants, industrial facilities, and oil refineries. Piperazine, known for its high reactivity with carbon dioxide, is being increasingly adopted in amine-based CO2 absorption processes to improve efficiency and reduce operational costs. According to the IEA, in 2023, the announced carbon capture capacity for 2030 increased by 35%, while the announced storage capacity grew by 70%. This expansion raised the total projected CO2 capture capacity for 2030 to approximately 435 million tonnes (Mt) per year, with the announced storage capacity reaching around 615 Mt of CO2 annually.

Traditionally, monoethanolamine (MEA) and diethanolamine (DEA) have been the primary solvents used for CO2 capture. However, these solvents often suffer from limitations such as low absorption capacity, high energy consumption for regeneration, and degradation over time. In contrast, piperazine has demonstrated superior reaction kinetics, higher CO2 absorption capacity, and improved thermal stability, making it an attractive alternative. It is commonly used in combination with other amines, such as methyldiethanolamine (MDEA) and MEA, to enhance the overall effectiveness of CO2 capture processes.

Key Market Players

BASF SE
Dow Inc.
Evonik Industries AG
Solvay S.A.
Albemarle Corporation
Shell plc
Huntsman Corporation
Akzo Nobel N.V.
Diamines and Chemicals Limited (DACL)
Shaoxing Xingxin New Materials Co., Ltd

Report Scope

In this report, the Global Piperazine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Piperazine Market, By Source:

Natural
Synthetic

Piperazine Market, By Application:

Pharmaceutical
Agrochemicals
Personal Care & Cosmetics
Others

Piperazine Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Piperazine Market.

Available Customizations:

Global Piperazine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Piperazine Market

5. Global Piperazine Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value & Volume
5.2. Market Share & Forecast
- 5.2.1. By Source (Natural, Synthetic)
- 5.2.2. By End Use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Piperazine Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value & Volume
6.2. Market Share & Forecast
- 6.2.1. By Source
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Piperazine Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Source
    - 6.3.1.2.2. By End Use
- 6.3.2. Mexico Piperazine Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Source
    - 6.3.2.2.2. By End Use
- 6.3.3. Canada Piperazine Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Source
    - 6.3.3.2.2. By End Use

7. Europe Piperazine Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value & Volume
7.2. Market Share & Forecast
- 7.2.1. By Source
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Piperazine Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Source
    - 7.3.1.2.2. By End Use
- 7.3.2. Germany Piperazine Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Source
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Piperazine Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Source
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Piperazine Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Source
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Piperazine Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Source
    - 7.3.5.2.2. By End Use

8. Asia Pacific Piperazine Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value & Volume
8.2. Market Share & Forecast
- 8.2.1. By Source
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Piperazine Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Source
    - 8.3.1.2.2. By End Use
- 8.3.2. India Piperazine Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Source
    - 8.3.2.2.2. By End Use
- 8.3.3. South Korea Piperazine Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Source
    - 8.3.3.2.2. By End Use
- 8.3.4. Japan Piperazine Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Source
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Piperazine Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Source
    - 8.3.5.2.2. By End Use

9. South America Piperazine Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value & Volume
9.2. Market Share & Forecast
- 9.2.1. By Source
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Piperazine Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Source
    - 9.3.1.2.2. By End Use
- 9.3.2. Argentina Piperazine Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Source
    - 9.3.2.2.2. By End Use
- 9.3.3. Colombia Piperazine Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Source
    - 9.3.3.2.2. By End Use

10. Middle East and Africa Piperazine Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value & Volume
10.2. Market Share & Forecast
- 10.2.1. By Source
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Piperazine Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Source
    - 10.3.1.2.2. By End Use
- 10.3.2. Saudi Arabia Piperazine Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Source
    - 10.3.2.2.2. By End Use
- 10.3.3. UAE Piperazine Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Source
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Source Launches (If Any)
12.3. Recent Developments

13. Global Piperazine Market: SWOT Analysis

14. Porters Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. Competitive Landscape

15.1. BASF SE
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Dow Inc.
15.3. Evonik Industries AG
15.4. Solvay S.A.
15.5. Albemarle Corporation
15.6. Shell plc
15.7. Huntsman Corporation
15.8. Akzo Nobel N.V.
15.9. Diamines and Chemicals Limited (DACL)
15.10. Shaoxing Xingxin New Materials Co., Ltd